Pfenex Inc 's ROA from the second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pfenex Inc 's ROA in the second quarter of 2020?
Pfenex Inc recorded a cumulative net loss of $-6 million during 12 months ending in the second quarter of 2020, resulting in a negative return on assets (ROA) of -6.99%.

However, within the Healthcare sector 280 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2020 from 3256 to 3324.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter
Y / Y Total Assets Change	31.27 %	28.59 %	3.12 %	-22.54 %	-36.69 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-6	-3	1	-17	-31
Return On Assets (TTM)	-6.99 %	-3.95 %	1.42 %	-24.3 %	-40.61 %
PFNX's Total Ranking	# 3324	# 3256	# 3415	# 3920	# 4208
Total Assets (TTM) in million	84	93	84	69	64
Seq. Total Assets Change	-9.27 %	10.69 %	20.9 %	8.11 %	-11.12 %
Seq. Net Income Change	-	-	277.49 %	-	-

PFNX's 5 Years Annual ROA >> Back to PFNX Management Effectiveness >> Compare PFNX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 90
Sector	# 281
Overall	# 3215

Return On Assets Statistics
High	Average	Low
32.53 %	-14.94 %	-48.28 %
(Dec 31 2014)		(Sep 30 2017)

Financial Statements
Pfenex Inc 's Assets	$ 84 million	PFNX's Balance sheet
Pfenex Inc 's Income	$ -10 million	Quarterly PFNX's Income Statement
PFNX's Income by Division		See PFNX's Income by Division

Annual Return On Assets	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2016) FY 2016	(Dec 31 2015) FY 2015
Y / Y Total Assets Change	4.44 %	2.38 %	-23.01 %	-21.7 %	85.42 %
Total Assets in million	85	81	79	103	132
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	1	-40	-26	5	-28
Annual Return On Assets	1.25 %	-48.71 %	-32.35 %	5.32 %	-21.43 %

PFNX's 5 Years Annual ROA >> Back to PFNX Management Effectiveness >> Compare PFNX ROA to its Competitors

Comment on PFNX's ROA in the fiscal year ending 2019

In the fiscal year 2019 ROA improved to 1.25 % compared to prior year, due to annual net income growth of % to $1.06 million, while value of Pfenex Inc 's overall assets grew just by 4.44 % to $84.89 million, compared to $84.89 a year before.

More Return On Assets Ratios
PFNX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PFNX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PFNX's Competitors
Subscribers only: Roa for Pfenex Inc 's Suppliers
Subscribers only: Return On Assets for PFNX's Customers

You may also want to know
PFNX's Roi	PFNX's Inventory Turnover Ratio	PFNX's Growth Rates	PFNX's Dividend Comparisons
	PFNX's Profitability Ratios	PFNX's Asset Turnover Ratio	PFNX's Dividend Growth
PFNX's Roe	PFNX's Valuation Ratios	PFNX's Financial Strength Ratios	PFNX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2020, within Healthcare Sector

ROA

Date modified: 2026-08-29T17:23:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.